Comparison of two validated nomograms in patients with localized soft tissue sarcoma of the extremities and trunk wall [0.03%]
两种经验证的列线图在局部肢体和躯干软组织肉瘤患者中的对比研究
Tadashi Iwai,Kiyohito Takamatsu,Sho Dohzono et al.
Tadashi Iwai et al.
Evaluation of cardiac markers in patients with breast cancer receiving antineoplastic treatment: a systematic review [0.03%]
评估心脏生物标志物在抗肿瘤治疗乳腺癌患者中的应用：系统评价研究
Tiago Nunes da Silva Soares,Thaís Moura Gascón,Fernando Luiz Affonso Fonseca et al.
Tiago Nunes da Silva Soares et al.
Background: Cardiac markers are important in the diagnosis of heart and coronary insufficiency, it is through them that they can measure the damage to cardiac fibers resulting from these diseases. Recent research has show...
ROS1 therapy among patients with advanced non-small cell lung cancer: an endless road to rediscover? [0.03%]
ROS1治疗在晚期非小细胞肺癌患者中的应用：一条不断探索的无尽之路？
Gilson Gabriel Viana Veloso,Nathalia Gimenes Afonso,Carlos Gil Ferreira
Gilson Gabriel Viana Veloso
Response to DNA-damaging agents and PARP inhibitors in ATM mutated metastatic colorectal cancer: case series [0.03%]
阿特密突变的转移性结直肠癌患者对DNA损伤剂和PARP抑制剂的反应：病例系列报告
Cody Eslinger,Daniel Walden,Mohamad Bassam Sonbol et al.
Cody Eslinger et al.
Background: The ataxia-telangiectasia mutated (ATM) gene is central to homologous recombination (HR) repair and cell-cycle checkpoint control. Pathogenic ATM mutations are increasingly recognized in metastatic colorectal ...
Yingqi Gu,Yujin Peng,Xiaofang Li
Yingqi Gu
Background and objective: Radiotherapy (RT) not only induces lethal DNA damage in tumor cells but also modulates the tumor immune microenvironment (TIME). It enhances the release of pro-inflammatory mediators and promotes...
Nonsurgical hepatocellular carcinoma treated with selective internal radiation therapy and personalized dosimetry: real-life data from French centers [0.03%]
法国中心治疗非手术肝细胞癌选择性内放射治疗和个人化剂量的实际情况数据
Louis Carmarans,Claude Somma,Victoria Ramdour et al.
Louis Carmarans et al.
Background: How selective internal radiation therapy (SIRT) with personalized dosimetry fits with intermediate and advanced hepatocellular carcinoma (HCC) treatment remains unclear. The aims of our study were to investiga...
A comparison of outcomes for patients with localized pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherapy with and without radiation prior to curative-intent resection: an analysis of the National Cancer Database [0.03%]
局部胰腺导管腺癌患者在接受根治性手术前单独使用新辅助化疗或联合放疗的疗效比较：基于国家癌症数据库的分析研究
Cade F Bennett,Lauren M Janczewski,Dominic Vitello et al.
Cade F Bennett et al.
Patient-reported outcomes in LITESPARK-005: a timely step toward patient-centered metrics in advanced renal cell carcinoma [0.03%]
LITESPARK-005研究中的患者报告结果（PRO）：迈向晚期肾细胞癌以患者为中心的疗效指标的重要一步
Firas Hatoum,Brandon Dyer,Nadine Mahmoud et al.
Firas Hatoum et al.
Identifying risk factors for refractory tyrosine kinase inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer [0.03%]
非小细胞肺癌酪氨酸激酶抑制剂相关难治性间质性肺疾病的危险因素分析
Wei Huang,Hejing Ye,Yanlin Zhu et al.
Wei Huang et al.
Background: Tyrosine kinase inhibitors (TKIs) are crucial targeted therapies for non-small cell lung cancer (NSCLC) patients harboring driver gene mutations. TKI-induced interstitial lung disease (TKI-ILD) is uncommon but...
The joint impact of sleep duration and physical activity on all-cause and cancer-specific mortality in cancer survivors: a retrospective cohort study based on NHANES 2005-2018 [0.03%]
基于NHANES(2005-2018)的回顾性队列研究：睡眠时长和身体活动对癌症幸存者全因及癌症特异性死亡率的联合作用
Jiao Wang,Tao Li
Jiao Wang
Background: Cancer survivors exhibit elevated mortality risks compared to the overall population, despite the known individual benefits of adequate sleep and physical activity in the general population, the interactive ef...